Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001005477-01-000712
Filing Date
2001-02-07
Accepted
2001-02-07 00:00:00
Documents
1
Group Members
HAROLD R. WERNERHEALTHCARE PARTNERS II, L.P.HEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE VENTURES II LPHEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILDWILLIAM CROUSE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G 0001.txt SC 13G/A 39581
  Complete submission text file 0001005477-01-000712.txt   41953
Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

EIN.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address BUILDING 75, 3RD AVENUE BLDG 96 13TH ST CHARLESTOWN MA 02129 6172415200
BIOTRANSPLANT INC (Subject) CIK: 0000880259 (see all company filings)

EIN.: 043119555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48065 | Film No.: 1527171
SIC: 2834 Pharmaceutical Preparations